Funnelfeedr Logo

Abarceo Pharma AB

Sverige559139-7160Active

Developing novel small molecule therapeutics targeting VDAC1 for diabetes.

Biotechnology Companyabarceo.com

Översikt

5–9
Anställda
2.5–5milj SEK
Omsättning
2017
Grundat

Nyckelbeslutsfattare

Mozhgan Dorkhan

Consulting CMO

Adam Bruce

CEO

Claes Post

Board Member

Claes Wollheim

CSO & Scientific Founder, Board Member

+11 fler kontakter i Funnelfeedr

Beskrivning

Abarceo Pharma is a pre-clinical stage biotechnology company founded in 2017 as a spin-out from the Lund University Diabetes Center. It was established by world-renowned scientists specializing in diabetes research and beta-cell biology. The company has identified Voltage-Dependent Anion Channel 1 (...

Taggar

B2BHealthcarePharmaceuticalsProfessional ServicesWhite Collar

Nyckelord

BiotechDiabetes TherapeuticsDrug DiscoveryMitochondrial DysfunctionType 2 DiabetesVDAC1 Target

Teknikstack

jQuery MigratejQueryBootstrapPriority HintsWordPressVarnishApache HTTP ServerPHPMagnific PopupFitVids.JSEasy Pie ChartYouTubejQuery Mobile

Företagsinformation

Bransch
Bioteknisk forskning och utveckling
Juridisk form
Aktiebolag
Momsnummer
SE559139716001

Beslutsfattare

15 kontakter i Funnelfeedr

Mozhgan Dorkhan

Consulting CMO

Adam Bruce

CEO

Claes Post

Board Member

Claes Wollheim

CSO & Scientific Founder, Board Member

Per Aniansson

Chairman of the Board

Ulrich Koch

Independent Board Member

William Dalby Brown

Head of Medicinal Chemistry and Screening

Henrik Otendal

CFO

Tara Heitner

Vice Chair

Albert Salehi

Scientific Founder

Jan Alenfall

COO

Övriga kontakter

Steven Kahn

Scientific Advisor

Michael Karin

Scientific Advisor

Kent Bodensgaard

Scientific Advisor

Ruchi Jain

Principal Scientist

Liknande företag

20 liknande företag i Funnelfeedr

Utforska mer

Frågor om Abarceo Pharma AB

Vill du se Funnelfeedr i praktiken?

Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.

Boka en demo